Record Gross Margin Post-Novellus, $5.4B FY25 FCF — But Dec Q GM Step-Down + China Overhang Drive -8% T+1 Gap-Down; Initiating at Hold

Results vs. Consensus

Year-over-Year Comparison

Quarter-over-Quarter Comparison

Revenue Assessment

The Q4 print at $5.17B (+10% QoQ; beat $5.04B Street by $130M) closes a record FY25 at $18.4B in revenue (+16% YoY). The composition is the structural positive: foundry systems revenue hit a record 52% of systems mix (vs 48% Q3) on continued leading-edge investments (GAA at TSMC, Samsung, Intel) + mature-node spending by domestic Chinese customers. NAND surprisingly bounced back to 27% of systems mix (vs 20% Q3) on upgrade revenue accelerating to a 3rd consecutive record level — Lam expects $40B of total NAND upgrade spending over the next several years. DRAM softened to 14% (vs 23% Q3) on timing of customer projects, but FY25 DRAM revenue still set a new record on technology upgrades (1-beta and 1-gamma nodes for DDR5/LPDDR5).

The Sep Q (Q1 FY26) guide of $5.20B ± $300M implies essentially flat revenue sequentially with strong China foundry spending offsetting other moderation. The Dec Q (Q2 FY26) implied revenue of ~$4.7B (per CFO's "look like March did") would represent ~10% sequential decline — meaning H1 FY26 (Sep+Dec) is roughly flat with H2 FY25 (Mar+Jun) at ~$9.9B vs ~$9.87B. WFE is flat half-on-half per management; Lam's revenue is mirroring that pattern.

Margin Assessment

The 50.3% gross margin is the structural surprise of the quarter — first time since the Novellus merger in 2012 that Lam has cleared 50%. The CFO's commentary attributed it to "stronger mix and continued progress in our operational efficiencies from our close to customer manufacturing strategy" — the close-to-customer manufacturing footprint (Asia regional manufacturing) is delivering structural cost benefits. The two-quarter sequence of 49.0% → 50.3% suggests the operational discipline is durable.

But the Dec Q gross margin step-down to ~48% (CFO-explicit) is the near-term concern. Drivers: (a) mix shift back toward higher domestic-China customer base (lower margin per the China-policy treatment); (b) tariffs "ticking up a little bit"; (c) lower top-line absolute revenue creates negative operating-leverage. The Sep guide of 50% ± 1pp holds the structural record line; the Dec setup gives some of it back. We model Q1 FY26 GM at 50.0%, Q2 FY26 GM at 48.0%, and full-year FY26 GM at 49.5% — below the FY25 peak but still structurally healthy.

Operating margin at 34.4% is +390bps YoY. The combination of revenue growth + mix improvement + cost discipline drove the operating-leverage story to record territory. FY25 operating margin at 34.4% Q4 (consolidated for the year ~34%) is well above the FY24 ~30% level. Continued progress on Lam's Investor Day target of "long-term value creation through profitability expansion" is empirically validated.

EPS & Cash Flow Assessment

Non-GAAP EPS of $1.33 exceeded the high end of guide ($1.20) — driven by (a) higher revenue, (b) stronger gross margin, and (c) lower tax rate at 4.8% (vs prior estimate of ~13%) due to a tax reserve release on statute of limitations. The CFO explicitly noted the tax rate "should be back in the low- to mid-teens range" for Sep Q — meaning the Q1 FY26 EPS guide of $1.20 ± $0.10 implicitly normalizes the tax rate back up, which would otherwise have been ~$1.30-1.40 at the Q4 tax rate. So underlying operating EPS continues to compound, but the headline EPS comparisons need normalization.

FY25 free cash flow of $5.4B (29% of revenue) is the record metric for the year. Cash position grew to $6.4B (from $5.5B Q3) driven by operating cash flow + customer advance payments ($670M increase in deferred revenue from "several newer customers" — likely tied to leading-edge GAA + advanced packaging commitments). Capex of $172M in Q4 (down from $288M Q3) reflects normalization after manufacturing buildout; CHIPS Act benefits provided $50M+ offset. Share buyback of $1.3B in Q4 (open market + ASR continuing into Sep) + $295M dividends = $1.6B of capital return in Q4 alone. $7.5B remaining buyback authorization provides multi-quarter cushion.

Segment Performance

Foundry — 52% of Systems Revenue (Record)

Foundry hit a record 52% of systems revenue (up from 48% Q3 and the second consecutive record quarter in dollar terms). The drivers, per the CEO: continued momentum in leading-edge processes (TSMC N2/A16, Samsung 2nm, Intel 18A all in scaling phase) + mature-node investments by domestic Chinese customers. The structural growth in foundry SAM is tied to (a) GAA architecture transition (3x metal deposition SAM increase from FinFET → GAA per wafer; Lam ALD moly the differentiated solution); (b) advanced packaging growing from 1% of foundry-logic WFE in 2021 to 6%+ today; (c) backside power coming as next inflection where Lam etch/deposition is well-positioned.

Lam disclosed a new ALD moly win at a leading foundry customer in Q4 for next-generation applications. The flexibility of the multi-station architecture (plasma + thermal processing in same chamber) is the differentiated capability for customer requirements across multiple device generations. Today, Lam is the only company with ALD moly tools in production at foundry/logic.

"AI is driving greater transistor performance requirements and, in turn, accelerating the inflection to gate-all-around device architectures. However, below 2 nanometers, gate-all-around structures begin to encounter significant resistance capacitance or RC challenges. Narrower transistor contacts in these devices cause greater electrons gathering, resulting in higher resistance of the deposited tungsten films. Replacing tungsten with molybdenum solves the resistance problem... This is driving a roughly 3x increase in Lam metal deposition SAM per wafer when transitioning to advanced gate-all-around nodes. Today, we are the only company with ALD Moly tools already in production in foundry/logic." — Tim Archer, CEO

Assessment: Foundry is the structural growth engine. The combination of GAA SAM expansion + ALD moly differentiation + advanced packaging momentum creates a multi-year revenue acceleration setup. We model foundry as the largest segment contributor to FY26 growth, sustaining 50%+ of systems mix.

NAND & Advanced Packaging — Upgrade-Driven Compounding

NAND surprised positively at 27% of systems mix (vs 20% Q3), driven by Upgrades revenue setting a 3rd consecutive record. The structural opportunity per the CEO: $40B of total NAND upgrade spending over the next several years as customers migrate to higher layer count + higher performance devices for AI applications. The Vantex system with cryo etch won a multi-generation NAND etch decision at a major NAND customer in Q4 — strengthening Lam's high-aspect-ratio dielectric etch leadership.

Advanced packaging continues to compound. Foundry-logic advanced packaging spend grew from 1% of WFE in 2021 to 6%+ today (more than 6x in 4 years). SABRE 3D market share in advanced packaging expected to grow ~5 points YoY in CY2025. Lam achieved 6,000 installed plating sales milestone in Q4. Cell-bonded-to-array (CBA) or cell-under-array architectures emerging on every NAND maker's roadmap.

Assessment: NAND + advanced packaging is the second structural growth engine. The $40B 5-year NAND upgrade opportunity + 5pp advanced packaging market share gain in CY25 + HBM 3E/4E adoption all compound. The HBM 4 transition (mentioned in Q&A) requires ~30% more wafers vs HBM 3 to produce equivalent bits — direct WFE tailwind.

DRAM — Project Timing Drove Sequential Decline; FY25 Record

DRAM at 14% of systems mix (down from 23% Q3) reflects timing of customer projects rather than structural softness. FY25 DRAM revenue set a new dollar record on technology upgrades to 1-beta and 1-gamma nodes (DDR5/LPDDR5) + High Bandwidth Memory investment.

The Akara conductor etch tool secured multiple new application wins at a top DRAM maker in Q4. The combination of direct power coupling + Lam's plasma pulsing capabilities delivers industry-leading depth uniformity and profile control — critical for DRAM scaling at 1-beta and 1-gamma nodes.

Assessment: The DRAM sequential decline is project-timing, not a structural concern. We model DRAM contribution at 18-22% of systems mix in FY26 with HBM driving the underlying growth.

China — 35% of Revenue, Multinationals Surging

China at 35% of total revenue (vs 31% Q3) is the highest level since Q4 2022. The composition is what matters: global multinationals investing in China grew +90% QoQ — the biggest sequential jump in years. Domestic Chinese customers remain the majority of China revenue but the multinational acceleration is the new structural data point.

The CFO's $700M China revenue restriction commentary (from prior December 2024 trade rules) remains intact: "Regulations haven't changed, so that's no different." Translation: the Q4 strength is incremental upon the restricted baseline, not a relaxation of policy. Cannot identify it as a specific tariff pull-in but acknowledged the "fluid" situation.

Assessment: China is structurally meaningful but policy-dependent. The 35% concentration creates tariff/policy tail risk. We monitor for any changes to U.S. export controls (likely a Q1 FY26 watch item).

Key Topics & Management Commentary

Overall Management Tone: Management was confident and execution-focused. The CEO opened with "Lam delivered another great quarter" and highlighted record metrics across multiple dimensions. The CFO matched the tone with specific record-level disclosures and provided unusually explicit Dec Q gross margin guidance (~48% — equal to consensus). The forward narrative emphasized SAM expansion + share gain through technology inflections, with the WFE +$5B raise to $105B being primarily domestic-China-driven. The notable cautious notes: explicit Dec Q gross margin step-down framing (the CFO directly said "you should be kind of thinking about where consensus is today, which is about 48%"); explicit Dec Q revenue commentary ("look largely top line wise, like March did roughly"); acknowledgment that tariffs are "ticking up a little bit" without quantification.

1. SAM Expansion to Mid-30s% of WFE (Investor Day Framework)

The CEO reiterated the multi-year SAM expansion target — Lam's served available market is set to expand to "around mid-30s percent of WFE" in 2025, with a longer-term path to "high 30% range" through atomic-level scaling, new materials, and advanced packaging integration. The strategic positioning: "win over 50% share of the incremental SAM over time."

"In 2025, Lam's served available market, or SAM, is set to expand to around mid-30s percent of WFE due to these industry drivers and we expect them to work in Lam's favor again in 2026. Longer term, we are on a solid path to grow our SAM to the high 30% range of WFE by continuing to deliver critical solutions for atomic level device scaling, new materials innovation and advanced packaging integration. The key R&D investments that we've made over the last several years have enabled us to create the broadest, most competitive product portfolio in the company's history, thereby putting us in a strong position to win over 50% share of the incremental SAM over time." — Tim Archer, CEO

Assessment: The SAM expansion framework is the structural multi-year thesis. Tool revenue growth of 3x WFE growth rate (acknowledged by Cantor's analyst in Q&A) is the empirical validation. We model Lam revenue growing in mid-teens YoY through FY26-27 even on flat WFE.

2. ALD Moly — Differentiated Technology for GAA <2nm

The ALD moly story is the most consequential technology disclosure of the call. As gate-all-around device structures scale below 2nm, narrower transistor contacts create resistance challenges with tungsten. Replacing tungsten with molybdenum solves the resistance problem; ALD moly is the deposition technique. Lam is the only company with ALD moly tools in production at foundry/logic. Q4 saw a new win at a leading foundry customer for next-generation applications.

The structural implication: 3x metal deposition SAM increase per wafer when transitioning to advanced GAA nodes. Combined with the multi-station architecture flexibility (plasma + thermal in same chamber), Lam has a differentiated technology moat in the most critical layer of foundry GAA production.

Assessment: ALD moly is the next-decade WFE growth lever. Lam's "only company with tools in production" positioning + customer-specific wins at multiple foundries creates a multi-year revenue acceleration runway. We model ALD moly contributing $300-600M of FY26 revenue with substantial upside as adoption broadens.

3. Advanced Packaging — 6x Growth Since 2021

Advanced packaging spend at foundry-logic customers grew from 1% of WFE in 2021 to "more than 6x" today. The CEO disclosed the next phase: SABRE 3D market share expected to grow ~5 points YoY in CY2025; 6,000 installed plating sales milestone reached. Future mainstreaming into end-consumer devices (mobile application processors, laptop CPUs) as on-device AI proliferates.

"Advanced packaging is critical for scaling system performance to address next-generation AI requirements and so far has enabled up to 100% improvement in memory density, 4x improvement in bandwidth and an approximate 40% gain in power efficiency. Lam SAM is growing with greater adoption of next-generation packaging architectures for DRAM, CPUs, GPUs and ASICs used in data centers. In 2021, leading-edge foundry/logic customers spent just 1% of WFE on advanced packaging. With AI's rapid adoption of advanced packaging, that number has grown more than 6x." — Tim Archer, CEO

Assessment: Advanced packaging is one of Lam's highest-growth SAM expansion levers. The 5pp YoY market share gain in CY25 + 6,000 installed plating sale base = compounding share + market growth. We model advanced packaging as a $2.5-3B+ revenue contributor for Lam in CY25 (was likely $1.5-2B in CY24), with continued double-digit YoY growth through CY27.

4. NAND Upgrade Cycle — $40B Multi-Year Opportunity

The CFO disclosed: "NAND investments focused primarily on upgrades, which we anticipate will require an investment of roughly $40 billion over several years." Translation: the structural NAND upgrade opportunity is $40B over a multi-year horizon — driven by layer count increases (200+ layers) + AI workload performance requirements + cell-bonded-to-array architectures emerging.

Q4's NAND upgrade revenue was a 3rd consecutive record. The Vantex cryo etch system won a multi-generation NAND etch decision at a major customer — strengthening Lam's high-aspect-ratio dielectric etch leadership. The ALD moly tool family is ramping at multiple NAND customers for higher-layer-count adoption.

Assessment: NAND upgrades are a structurally healthy multi-year revenue line. The $40B 5-year opportunity = $8B/year average for the industry; Lam should capture 30-40% share = $2.5-3.2B/year contribution. We model NAND upgrade revenue at $1.5-2B for FY26 with growth as the upgrade cycle accelerates.

5. China Region — 35% of Revenue, Policy Uncertainty

China at 35% of total revenue (vs 31% Q3) reflects multinational acceleration (+90% QoQ from global multinationals in China) on top of the steady domestic Chinese customer base. The CFO maintained the $700M revenue impact from December 2024 trade restrictions remains intact; regulations have not changed.

"Yes, that $700 million number that was revenue we had identified to specific customers. Regulations haven't changed, so that's no different. I think when we think about the fact that WFE is a little bit stronger, and it's driven by a little bit more spending in China, it's just a little bit more spending from a handful of customers is how I would be thinking about it. It's nearly impossible for us to say it's a pull-in because of any specific reason. They're just spending a little bit more when we unpack it." — Doug Bettinger, CFO

Assessment: China is the structural watch item. 35% concentration creates policy/tariff tail risk that compresses the multiple. We monitor for any U.S. export control changes (likely a Q1 FY26 update).

6. CSBG (Customer Support Business Group) — Upgrade Revenue Compounding

CSBG revenue ran $1.7B in Q4 — flat with Q3 and Q4'24 — but the composition matters: 3rd consecutive record upgrade revenue driven by NAND technology conversions. The CFO expects "modest growth in CSBG for the calendar year."

The structural value: CSBG provides recurring revenue with high-margin upgrade revenue (typical 60%+ gross margin) supporting the consolidated margin. As NAND upgrade demand accelerates over the next several years, CSBG should compound — providing a counter-cyclical floor during WFE downturns.

Assessment: CSBG is the structural floor. The flat $1.7B run-rate today is the foundation; the $40B 5-year NAND upgrade opportunity provides the growth lever. We model CSBG growing to $7.0-7.5B FY26 (vs FY25 ~$6.8B) on upgrade revenue acceleration.

7. CY2025 WFE Raised to $105B; CY2026 "Bias Up"

Lam raised the CY2025 WFE outlook to $105B (from prior $100B) — a +$5B upward revision driven entirely by domestic China spending. H2 25 WFE expected to be roughly flat with H1 25. The CY2026 outlook was characterized as "too early to comment on the overall level of WFE spending" but with a clear directional positive: Lam is "well positioned to outperform" given strong positions in GAA, advanced packaging, HBM, and NAND layer conversions.

"We expect wafer fabrication equipment, or WFE spending to be in the $105 billion range, up from our prior view of approximately $100 billion, predominantly due to an uptick in domestic China related spending. We see non-China investments remaining broadly consistent with our prior view. Currently, we expect WFE in the second half of the calendar year to be roughly flat with the first half. Looking forward to 2026, it is still too early to comment on the overall level of WFE spending. However, our strong position in gate- all-around, advanced packaging, high-bandwidth memory and NAND layer conversions, we feel confident that Lam is well positioned to outperform." — Tim Archer, CEO

Assessment: The +$5B WFE raise is positive but more than offset in the near-term narrative by the Dec Q setup. We model CY26 WFE at $110-115B (modest growth from CY25 $105B) with Lam's SAM expansion delivering relative outperformance regardless of total WFE direction.

8. Capital Return — $1.6B Q4 Total ($1.3B Buyback + $0.3B Dividend)

Lam allocated $1.3B to share buybacks in Q4 (combination of open market + ASR continuing into Sep) + $295M in dividends = $1.6B of capital return. $7.5B remains on the Board-authorized share repurchase program. The diluted share count of 1.28B (down from prior quarter) was consistent with guidance.

Assessment: Aggressive capital return is the bull-case cushion. With $6.4B cash + $5.4B annual FCF + $7.5B buyback authorization, Lam has multi-year capital-return capacity. We model FY26 capital return at $5-6B with buybacks supporting EPS growth via share count reduction.

Guidance & Outlook

The Sep Q (Q1 FY26) guide is broadly in-line, with revenue modestly above Street and the EPS/margin lines holding the structural records from Q4. The Dec Q (Q2 FY26) setup is the wrinkle: explicit guidance to ~$4.7B revenue (down ~10% from Sep) + ~48% gross margin (down ~200bps from Sep) = the structural sandbag that compressed near-term enthusiasm.

Implied FY26 H1 trajectory: Sep $5.2B + Dec $4.7B = $9.9B H1 revenue (vs FY25 H2 $9.87B = roughly flat). Sep gross margin 50% + Dec 48% = ~49% H1 average. Non-GAAP EPS Sep $1.20 + Dec ~$1.05 = ~$2.25 H1 (vs FY25 H2 ~$2.58 H1 = -13% YoY pressure). Street at: FY26 consensus was $5.20B Sep + $5.25B Dec = -$1.05B vs the implied guide. Sell-side will revise Dec down. Guidance style: Lam typically guides conservatively and beats by 1-3% on revenue and 5-15% on EPS. The Dec guidance is more explicit/conservative than usual — suggesting either genuine softness or unusual sandbagging.

Analyst Q&A Highlights

Outperformance Framework — Tool Business Growing 3x WFE

The opening question framed the structural debate: Lam's tool business growing 3x WFE growth rate is empirically validated; what's the rank order of drivers? The CEO's response cited GAA architecture transition (selective etch + ALD + backside power), advanced packaging across all device types, and continued NAND layer scaling.

Q: "I guess first question, your tool business is likely growing 3x the growth rate of WFE here in calendar '25, and you indicated expectations for relative outperformance to continue in calendar '26. Is there a framework for thinking about rank order of the key drivers of this outperformance that you could share?"
— C.J. Muse, Cantor Fitzgerald

A: "Sure. I think it's — it's all the things that we've talked about in the past. I mean, clearly, if we look at foundry/logic, I mentioned extensively the discussion of moly today, but we're also looking at other tools around the gate-all-around structure. It's things like selective etch, ALD. We still have backside power to come. That will be an area we believe of outperformance for Lam given our strength in etch and deposition in the role that it plays there. We continue to see ourselves gaining against WFE the more that advanced packaging is incorporated across every type of device, whether it's foundry/logic, HPM and even in NAND, we're starting to see on every NAND makers roadmap, things like cell bonded to array or cell under array."
— Tim Archer, CEO

Assessment: The "3x WFE growth rate" framework is the structural bull thesis articulation. Multiple compounding levers (GAA + advanced packaging + NAND scaling + backside power) provide independent growth vectors. We model Lam revenue growing +12-15% YoY in FY26-27 on flat-to-modestly-up WFE.

Dec Q Gross Margin Trajectory — CFO's Explicit 48% Framing

The follow-up question on gross margin trajectory drew the most direct guidance Lam has given on a forward quarter — the CFO explicitly told the Street to model December gross margin at ~48%, equal to current consensus.

Q: "And then a question for you, Doug. In terms of gross margins, you've got — it sounds like some tailwind from China. So curious, does that continue into the December quarter? And is there kind of a new normalized gross margin ex kind of China that we should be thinking about?"
— C.J. Muse, Cantor Fitzgerald

A: "Yes, it's Tim. We are benefiting from a favorable mix, both customer as well as a little bit of product. We do have some level of headwinds as I look forward. Tariffs are ticking up a little bit. I don't expect, as we get into the December quarter, we're going to continue to have quite as favorable of a level of mix. And so I'll be pretty direct about how I want everybody thinking about the December gross margin. You should be kind of thinking about where consensus is today, which is about 48%. I think that's what you're going to see in December. I'm not going to get over the SKUs yet in terms of what you should be thinking about as we head into next year because I'm not exactly sure what the mix is going to be, C.J., but I'll give you a very direct guidance on December, which I just did."
— Tim Archer, CEO

Assessment: The "pretty direct about how I want everybody thinking about the December gross margin" + "consensus is today, which is about 48%" framing is the structural sandbag pattern. Lam guides slightly below Street and beats by ~50-100bps consistently. We model Dec GM at 48-49% with operational levers providing modest upside.

Dec Q Revenue Trajectory — Mirror March Quarter

The UBS analyst pressed for Dec Q revenue context. The CFO's framing was unusually explicit: Dec revenue "look largely top line wise, like March did roughly" — meaning ~$4.7B vs Sep $5.2B guide, a ~10% sequential decline.

Q: "Doug, so taking your comment about gross margin being down does made — and I know it doesn't have a lot to do with volume. And also looking at the commentary about WFE being pretty flat half-on-half. I know you're going to gain share on the system side during the back half of the year for sure. But can you give us a little bit of a sense, like do you think that December revenue is down as well just like gross margin? Or do you think it's pretty flat?"
— Timothy Arcuri, UBS

A: "Yes, Tim, I mean, you should think about our revenue likely mirroring what we described a B2B, right? We told you we now think WFE is roughly flat half-on-half, flattish. And if you think through that, you know what March was. You know that both June and September are roughly the same revenue level so that you should conclude the December quarter look largely top line wise, like March did roughly."
— Doug Bettinger, CFO

Assessment: The "mirror March" framing is the cleanest forward-revenue signal. $4.7B Dec vs $5.2B Sep = ~10% sequential decline driving the stock's gap-down. We treat this as a structurally healthy sandbag pattern but acknowledge the near-term EPS pressure on H1 FY26.

CY2026 WFE Direction — "Bias to Next Year is Up"

The follow-up on CY2026 direction extracted the CEO's most-forward-looking commentary of the call. While formally declining to provide a CY26 WFE number, the CEO confirmed the bias to next year is up — driven by the same structural drivers (HBM, advanced packaging, GAA, NAND moly).

Q: "And then can you just talk about just there was — there's like a lot of puts and takes for next year. I know there was a pretty big CapEx cut from a big logic maker. But it sounds like you still feel like the bias to next year. I mean, you're not giving us the number. But if you had to, you would say that the bias to next year is up, is that fair?"
— Timothy Arcuri, UBS

A: "Well, we're not going to give a 2026 number. But I think that what we're trying to do is frame out that regardless of what WFE is, we think that the drivers of WFE spending are significantly in Lam's favor. I think that it's just too early. I mean there are tremendous number of projects in play right now. It's hard to know exact timing. But if you look, what are the drivers for '26, '27, '28, it's what I just talked about in the last question, HPM, advanced packaging, gate- all-around, NAND layer scaling, moly. We didn't talk about — I think mentioned dry resist, EUV patterning. These are all areas where Lam has new products that have been in our customers' R&D facilities for the last several years. They're ready to go. We don't control the customer's project timing, but we feel incredibly confident that when those projects go, Lam expands our SAM and gain share. That might be '26, it might be '27. Our strategy doesn't change at this point based on the customers' timing. We're in the right position."
— Tim Archer, CEO

Assessment: The CEO's "regardless of what WFE is, we think that the drivers of WFE spending are significantly in Lam's favor" framing is the structural bull case in one sentence. We model FY26 revenue growth at +10-15% YoY on the SAM expansion + share gain theses.

China Multinationals +90% QoQ — What Changed?

The JPMorgan question dissected the China multinational acceleration. The CFO confirmed the +90% QoQ growth from multinationals in China but declined to attribute it to any specific catalyst.

Q: "Your China business was strong in the June quarter. It was up about 20% sequentially. Is the team still embedding about a $700 million negative impact from China in the second half of this year due to the restrictions that were put in place back in December? But irrespective of that, on top of all of this, you're anticipating a better overall China business this year, right? So relative to 90 days ago, what has changed within your China customer base?"
— Harlan Sur, JPMorgan

A: "That $700 million number that was revenue we had identified to specific customers. Regulations haven't changed, so that's no different. I think when we think about the fact that WFE is a little bit stronger, and it's driven by a little bit more spending in China, it's just a little bit more spending from a handful of customers is how I would be thinking about it. It's nearly impossible for us to say it's a pull-in because of any specific reason. They're just spending a little bit more when we unpack it."
— Doug Bettinger, CFO

Assessment: The deliberate non-attribution preserves regulatory and competitive flexibility. The empirical data is clean: China multinationals +90% QoQ growth at the highest level since Q4 2022. We treat this as structurally positive but monitor closely for any policy changes.

Advanced Packaging + HBM Acceleration

The JPMorgan follow-up explored advanced packaging momentum specifically — whether the second-half shipment improvement is partly advanced-packaging-driven.

Q: "As we track a lot of these next-generation AI, XPU and GPU programs, like many of them are moving from 2.5D to 3D packaging. And then on the flip side, you have memory customers as you pointed out, are gearing up for a strong migration to HPM 4 next year, some of them are actually signaling increases in spending in the second half of this year, right, versus their expectations coming into the year... is that business coming in better versus your expectation of entering this year? And is that what is also helping to drive maybe a slightly better second half shipment and revenue profile?"
— Harlan Sur, JPMorgan

A: "It's a little bit, Harlan. I think advanced packaging total is probably a little bit stronger than we expected. It's not wildly stronger. But HPM is strong, and there's probably a little bit of upside related to that as well as the China stuff we were talking about... by our estimate, and I think some of our customers' commentary, you need approximately 30% more wafers to produce an equivalent number of bits when you move from 3D to 4D. So look, as AI performance requirements continue to demand these greater capabilities, we're just seeing increased WFE in the etch and deposition spaces."
— Doug Bettinger, CFO & Tim Archer, CEO

Assessment: The HBM 3 → 4 transition requiring 30% more wafers per equivalent bit is the structural WFE tailwind from memory. Combined with advanced packaging momentum, the AI-driven WFE intensity is compounding. We model HBM-related revenue at $1.5-2B for Lam in FY26 (vs FY25 ~$1B).

What They're NOT Saying

1. CY2026 WFE number: CEO explicitly "not going to give a 2026 number" — directional positive ("bias is up") only. We model $110-115B.
2. 2nm GAA customer wins specifics: CEO said "we don't comment about any one specific customer" — the ALD moly Q4 win was a "leading foundry customer for their next-generation application" but not named (likely TSMC, Samsung, or Intel).
3. Tariff dollar quantification: "Tariffs are ticking up a little bit" but no specific dollar impact on Q1 FY26 or H1 FY26 disclosed.
4. Specific China multinational customers driving the +90% QoQ: Multinationals in China grew dramatically QoQ but no customer-specific attribution.
5. Customer advance payments $670M increase: Tied to "several newer customers" but not named or sized individually.
6. Buyback pace through Sep ASR: ASR will "continue to execute into the September quarter" but specific Sep buyback amount not disclosed.
7. FY26 EPS run-rate: The Dec Q gross margin + revenue setup implies FY26 H1 EPS pressure vs FY25 H2, but no FY26 EPS guidance.

Market Reaction

• Pre-print setup (Jul 29 close): $98.94, +30%+ YTD from ~$70-75 base (Jan 2025). Volume normal. Positioning net-long on multi-quarter WFE cycle narrative.
• Day-of (Jul 30 print released after close): Regular close $99.09 (-0.43%); volume 12.5M. After-hours initial mix — gross margin record positive; Dec Q setup discussion negative.
• T+1 (Jul 31): Open $91.02 (gap DOWN -8.1%); intraday low $90.94; close $94.84 (-4.3% from Jul 30). Volume 27.66M (~3x normal). Pattern: gap-down on Dec Q gross margin step-down + revenue sequential decline; partial intraday recovery as the structural beat resonated.
• T+2 (Aug 1): Close $96.37 (+1.61%); partial recovery on the structural Q4 print + CY26 bias-up commentary.
• Sell-side reaction: Mixed — Buy ratings (JPMorgan, Goldman, Bank of America) maintained; Hold/Neutral (Bernstein, UBS) maintained. Some PT raises, some cuts. Generally cautious near-term on Dec Q setup.
• Peer reaction: AMAT down -2-3% on read-across; KLAC modestly down; broader SOXX down modestly.

The Q4 reaction is the structural feature of a high-quality industrial cyclical at peak FY-year metrics meeting a near-term sequential decline setup. The +30% YTD run-in had embedded high expectations for sustained acceleration; the Dec Q step-down (CFO-explicit) compressed those expectations. The market's -4.3% T+1 reaction is appropriate calibration to the new FY26 H1 setup — not a structural thesis break.

Street Perspective

Debate: Is Dec Q the bottom of the FY26 H1 trough or the start of a multi-quarter compression?

Bull view: Dec Q is the structural sandbag set by management. Lam's historical pattern is conservative guidance + execution beating by 1-3% on revenue and 5-15% on EPS. The "mirror March" framing is the explicit conservative anchor that builds in upside surprise capacity for Dec Q execution. Q1 FY26 actual will land at $5.2B+ revenue, Sep gross margin at 50.5%+, and Dec actual will print ~$4.85B+ vs the implied $4.7B. The FY26 H1 trough is a one-quarter event, not a multi-quarter compression.

Bear view: The CFO's unusually explicit Dec Q guidance (~48% GM, "mirror March" revenue) is signaling genuine softness, not sandbagging. The China multinational +90% QoQ surge is structurally one-time (tariff pull-in dynamics; not repeatable). FY26 H1 will compress materially vs FY25 H2 expectations; the FY26 EPS line will track ~$5.00 vs Street's ~$5.40 — a meaningful downside surprise.

Our take: Probability is ~70/30 bull (sandbag) vs bear (genuine softness). The 4-quarter trailing beat pattern + explicit sandbag-style framing favor the bull case. But the bear risk is real and warrants Hold rather than Outperform at this entry point. We need Q1 FY26 execution to validate the sandbag pattern before upgrading.

Debate: Is the structural SAM expansion narrative sufficient to drive multi-year EPS compounding through cyclical WFE chop?

Bull view: Lam's tool business growing 3x WFE growth rate (empirically validated CY25) is the structural alpha lever. SAM expansion to mid-30s% of WFE in CY25 + high 30%s by 2030 + 50%+ share of incremental SAM = Lam revenue compounding at high-single-digit to low-double-digit YoY rates regardless of WFE direction. Multi-year EPS compounding driven by share gain + margin expansion + buybacks supports a $200+ stock by FY27.

Bear view: Industrial-cyclical multiples compress in down-cycles regardless of structural alpha. WFE peaked at $105B in CY25; CY26-27 could see modest declines if memory pricing softens or foundry capex pulls back. Lam's share gain compounds against a declining absolute base = revenue growth muted in down years. The 3x-WFE-growth-rate framing requires WFE itself to grow; if WFE flattens or declines, Lam's relative outperformance produces modest absolute growth.

Our take: Both partly right. The SAM expansion is structurally durable; the WFE cyclicality creates near-term volatility. We model Lam revenue at $19.5-20.5B FY26 (+6-12% YoY from FY25 $18.4B) and $22-24B FY27 (+10-15% YoY) — durable growth above WFE cycle.

Debate: Does the China policy overhang justify a structural multiple discount?

Bull view: China at 35% of revenue is meaningful but management has executed through multiple rounds of trade restrictions (Oct 2022, Dec 2024) without material long-term revenue impact. The structural China demand (domestic foundries scaling on mature nodes; global multinationals investing in China for compliance) is durable. The $700M restriction impact is already in the baseline; further restrictions are unlikely to materially worsen.

Bear view: China policy is the structural tail risk. Any major tightening of U.S. export controls (e.g., advanced node restrictions, expanded entity lists) could remove $1-2B of annual revenue at lower-than-corporate margin. The 35% concentration creates the kind of policy risk that compresses the multiple regardless of operating execution. The multinational +90% QoQ surge may itself be tariff-driven pull-in, suggesting structural deceleration in H2 26.

Our take: China policy risk is real and bounded. The 35% concentration deserves some multiple discount, but Lam has navigated multiple policy cycles successfully. We treat China as the central risk-not-thesis-breaker variable.

Model Update Needed

Valuation impact: At Jul 31 close of $94.84 and ~1.28B diluted shares, market cap is ~$121B; cash $6.4B less long-term debt ~$5B = net cash $1.4B; EV ~$120B. On FY26E revenue $19.7B and non-GAAP EPS $4.85-5.10, LRCX trades at 6.1x EV/Sales and ~19x EV/EPS. Semis cap-equipment peer multiples: AMAT ~5x EV/Sales / 20x EV/EPS; KLAC ~7x EV/Sales / 24x EV/EPS; ASML ~9x EV/Sales / 30x EV/EPS. Lam at 6.1x EV/Sales is in-range vs AMAT but below the higher-quality KLAC/ASML reference set. Our 12-month fair-value estimate: $100-110 (5-16% above Jul 31 close) — limited upside given the Dec Q setup compression.

Thesis Scorecard Post-Earnings

Overall: The structural thesis is intact and incrementally strengthened (SAM expansion + ALD moly + advanced packaging + NAND upgrade). The near-term setup is the wrinkle — Dec Q gross margin step-down + revenue sequential decline + China policy uncertainty + stretched entry pricing.

Action: Initiating at Hold. The structural fundamentals support Outperform; the entry timing does not. We wait for Q1 FY26 execution to validate the sandbag pattern before upgrading. Re-rating triggers: Q1 FY26 prints at $5.4B+ revenue with gross margin sustaining at 50%+, AND Dec Q execution validates the structural sandbag pattern (Dec actual $4.85B+ vs implied $4.7B).